UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 366,753 shares of the company's stock after acquiring an additional 37,276 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.42% of HealthEquity worth $35,190,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently modified their holdings of the company. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity in the 4th quarter valued at $26,000. Transce3nd LLC acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $29,000. Smartleaf Asset Management LLC boosted its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $39,000. Finally, Skandinaviska Enskilda Banken AB publ boosted its stake in shares of HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after purchasing an additional 445 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.
HealthEquity Stock Up 0.1%
HQY traded up $0.13 during midday trading on Friday, hitting $101.11. The company had a trading volume of 960,737 shares, compared to its average volume of 809,286. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $8.75 billion, a price-to-earnings ratio of 92.76, a PEG ratio of 1.60 and a beta of 0.45. The stock's 50 day moving average price is $89.41 and its 200 day moving average price is $97.48.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on HQY shares. Royal Bank of Canada started coverage on shares of HealthEquity in a research report on Thursday, May 22nd. They issued an "outperform" rating and a $112.00 target price on the stock. KeyCorp cut their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. The Goldman Sachs Group cut their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Finally, Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their target price for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $112.33.
View Our Latest Research Report on HealthEquity
Insider Buying and Selling at HealthEquity
In related news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now directly owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company's stock.
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
